Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine as an adjunct to femoral nerve block after total knee replacement
NL-OMON37162Phase 4Withdrawn
- Sponsor
- Westfriesgasthuis
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of buprenorphine and ropivacaine in postoperative pain and knee osteoarthritis (OA) (3 arms), sponsored by Westfriesgasthuis. Planned start Aug 2012; status: withdrawn.
02
Drugs
buprenorphineropivacaine
03
Conditions
postoperative painknee osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON37162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37162.